Patients who experience an LAD (Left Anterior Descending artery) STEMI, or ST-elevation myocardial infarction, suffer a severe type of heart attack caused by complete blockage of a major coronary artery. This blockage drastically reduces blood flow to the heart muscle, leading to extensive tissue damage if not treated promptly.

Such events often result in structural distortion and remodeling of the left ventricle, ultimately progressing to advanced heart failure with reduced ejection fraction.

The Revivent System is designed to treat patients with ischemic heart failure and reduced ejection fraction resulting from extensive left ventricular scarring. These patients typically have a dilated left ventricle and have shown a suboptimal response to guideline-directed medical therapy. The goal of the Revivent procedure is to restore the shape and reduce the volume of the left ventricle, thereby improving overall cardiac function and performance.

Approximately 140k us prevalent STEMI patients are appropriate for Revivent due to anterior scarring, reduced ejection fraction, and limited capacity for physical activity.